4Richardson P,McKenna W,Bristow W,et al.Report of the 1995World Oganization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies[J].Circulation,1996,93:841-842.
5Waagstein F,Hjalmarson A,Vamarskas E,et al.Effect of chronic betaadrenergec receptor blockade in congestive cardiomyopathy[J].Br Heart J,1975,37:1022-1036.
6MERIT HF Study Group.Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL randomized intervention trial in congestiveheart failure (MERIT HF)[J].Lancet,1999,353(12):2001-2007.
7CIBIS-Ⅱ investigators and committees.The cardiac insufficiency bisoprolol study Ⅱ:A randomized trial[J].Lancet,1999,353 (2):9 -13.
8Packer M,Fowler MB,Roecker EB.Effect of carvedilol on the morbidity of patients with severe chronic heart failure:Results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study[J].Circulation,2002,106:2194-2199.
9Wojnicz R,Nowalany-Kozielska E,Wojciechowska C,et al.Random ized,placebo controlled study of inflammatory dilated cardiomyopathy:Two-year follow up results[J].Circulation,2001,104:39 -45.
